Secretome compartment is a valuable source of biomarkers for cancer-relevant pathways

Journal of Proteome Research

Volumn 10, Issue 9, 2011, Pages 4196-4207

  Caccia, Dario ^a   Zanetti Domingues, Laura ^a   Miccichè, Francesca ^a   De Bortoli, Maida ^a   Carniti, Cristiana ^a   Mondellini, Piera ^a   Bongarzone, Italia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

adhesion pathway; bioinformatics; network prediction; predictive biomarkers; proteomics; secretome; signaling pathways; targeted therapy

Indexed keywords

BIOLOGICAL MARKER; DASATINIB; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; NEOPLASM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASMS; PHOSPHOTYROSINE; PROTEOME; PYRIMIDINES; SIGNAL TRANSDUCTION; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL;

EID: 80052440879     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200344n     Document Type: Article

References (42)

1. Sawyers, C. L. The cancer biomarker problem Nature 2008, 452, 548-552 (Pubitemid 351483368)
2. Pavlou, M. P.; Diamandis, E. P. The cancer cell secretome: A good source for discovering biomarkers? J. Proteomics 2010, 73, 1896-1906
3. Tongyoo, A. Targeted therapy: novel agents against cancer J. Med. Assoc. Thai. 2010, 93 (Suppl 7) S311-S323
4. Goddard, K. A.; Weinmann, S.; Richert-Boe, K.; Chen, C.; Bulkley, J.; Wax, C. HER2 evaluation and its impact on breast cancer treatment decisions Public Health Genomics 2011, 10.1159/000325746
5. Cheng, L.; Zhang, S. B.; Alexander, R.; Yao, Y. X.; MacLennan, G. T.; Pan, C. X.; Huang, J. T.; Wang, M. S.; Montironi, R.; Lopez-Beltran, A. The landscape of EGFR pathways and personalized management of non-small-cell lung cancer Future Oncol. 2011, 7, 519-541
6. Baselga, J. Targeting tyrosine kinases in cancer: The second wave Science 2006, 312, 1175-1178 (Pubitemid 43801135)
7. Nazarian, R.; Shi, H.; Wang, Q.; Kong, X.; Koya, R. C.; Lee, H.; Chen, Z.; Lee, M. K.; Attar, N.; Sazegar, H.; Chodon, T.; Nelson, S. F.; McArthur, G.; Sosman, J. A.; Ribas, A.; Lo, R. S. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation Nature 2010, 468, 973-977
8. Escudier, B.; Eisen, T.; Stadler, W. M.; Szczylik, C.; Oudard, S.; Siebels, M.; Negrier, S.; Chevreau, C.; Solska, E.; Desai, A. A.; Rolland, F.; Demkow, T.; Hutson, T. E.; Gore, M.; Freeman, S.; Schwartz, B.; Shan, M.; Simantov, R.; Bukowski, R. M. Sorafenib in advanced clear-cell renal-cell carcinoma N. Engl. J. Med. 2007, 356, 125-134 (Pubitemid 46089673)
9. Lawlor, K.; Nazarlan, A.; Lacomis, L.; Tempst, P.; Villanueva, J. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes J. Proteome Res. 2009, 8, 1489-1503
10. Karagiannis, G. S.; Pavlou, M. P.; Diamandis, E. P. Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology Mol. Oncol. 2010, 4, 496-510
11. Schiarea, S.; Salinas, G.; Allavena, P.; Scigliuolo, G. M.; Bagnati, R.; Fanelli, R.; Chiabrando, C. Secretome analysis of multiple pancreatic cancer cell lines reveals perturbations of key functional networks J. Proteome Res. 2010, 9, 4376-4392
12. Gundacker, N. C.; Haudek, V. J.; Wimmer, H.; Slany, A.; Griss, J.; Bochkov, V.; Zielinski, C.; Wagner, O.; Stockl, J.; Gerner, C. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells J. Proteome Res. 2009, 8, 2799-2811
13. Gronborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.; Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; Maitra, A.; Pandey, A. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach Mol. Cell. Proteomics 2006, 5, 157-171 (Pubitemid 43169348)
14. Xue, H.; Li, B. J.; Zhang, J.; Wu, M. L.; Huang, Q.; Wu, Q.; Sheng, H. Q.; Wu, D. D.; Hu, J. W.; Lai, M. D. Identification of Serum Biomarkers for Colorectal Cancer Metastasis Using a Differential Secretome Approach J. Proteome Res. 2010, 9, 545-555
15. Dowling, P.; Clynes, M. Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease-specific biomarkers Proteomics 2011, 11, 794-804
16. Michel, P. E.; Reymond, F.; Arnaud, I. L.; Josserand, J.; Girault, H. H.; Rossier, J. S. Protein fractionation in a multicompartment device using Off-Gel (TM) isoelectric focusing Electrophoresis 2003, 24, 3-11 (Pubitemid 36175845)
17. Michel, P. E.; Crettaz, D.; Morier, P.; Heller, M.; Gallot, D.; Tissot, J. D.; Reymond, F.; Rossier, J. S. Proteome analysis of human plasma and amniotic fluid by Off-Gel (TM) isoelectric focusing followed by nano-LC-MS/MS Electrophoresis 2006, 27, 1169-1181
18. Caccia, D.; Micciche, F.; Cassinelli, G.; Mondellini, P.; Casalini, P.; Bongarzone, I. Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line Mol. Cancer 2010, 9
19. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0 J. Mol. Biol. 2004, 340, 783-795 (Pubitemid 38829638)
20. Nielsen, H.; Engelbrecht, J.; Brunak, S. vonHeijne, G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites Protein Eng. 1997, 10, 1-6
21. Bendtsen, J. D.; Jensen, L. J.; Blom, N.; von Heijne, G.; Brunak, S. Feature-based prediction of non-classical and leaderless protein secretion Protein Eng., Des. Sel. 2004, 17, 349-356 (Pubitemid 39093515)
22. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9, 4997-5000
23. Bhatia, V. N.; Perlman, D. H.; Costello, C. E.; Mccomb, M. E. Software Tool for Researching Annotations of Proteins: Open-Source Protein Annotation Software with Data Visualization Anal. Chem. 2009, 81, 9819-9823
24. Huang, D. W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4, 44-57
25. Dennis, G.; Sherman, B. T.; Hosack, D. A.; Yang, J.; Gao, W.; Lane, H. C.; Lempicki, R. A. DAVID: Database for annotation, visualization, and integrated discovery Genome Biol. 2003, 4
26. Makridakis, M.; Vlahou, A. Secretome proteomics for discovery of cancer biomarkers J. Proteomics 2010, 73, 2291-2305
27. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9, 4997-5000
28. Keller, M.; Ruegg, A.; Werner, S.; Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion Cell 2008, 132, 818-831 (Pubitemid 351312798)
29. Mathivanan, S.; Simpson, R. J. ExoCarta: A compendium of exosomal proteins and RNA Proteomics 2009, 9, 4997-5000
30. Valenti, R.; Huber, V.; Filipazzi, P.; Pilla, L.; Sovena, G.; Villa, A.; Corbelli, A.; Fais, S.; Parmiani, G.; Rivoltini, L. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes Cancer Res. 2006, 66, 9290-9298 (Pubitemid 44521151)
31. Dozmorov, M. G.; Hurst, R. E.; Culkin, D. J.; Kropp, B. P.; Frank, M. B.; Osban, J.; Penning, T. M.; Lin, H. K. Unique Patterns of Molecular Profiling Between Human Prostate Cancer LNCaP and PC-3 Cells Prostate 2009, 69, 1077-1090
32. Sakamoto, S.; Schwarze, S.; Kyprianou, N. Anoikis Disruption of Focal Adhesion-Akt Signaling Impairs Renal Cell Carcinoma Eur. Urol. 2011, 59, 734-744
33. Harris, T. J. R.; McCormick, F. The molecular pathology of cancer Nat. Rev. Clin. Oncol. 2010, 7, 251-265
34. Chee, C. E.; Sinicrope, F. A. Targeted Therapeutic Agents for Colorectal Cancer Gastroenterol. Clin. North Am. 2010, 39, 601-+
35. Bienz, M.; Clevers, H. Linking colorectal cancer to Wnt signaling Cell 2000, 103, 311-320
36. Lee, A. K.; Ahn, S. G.; Yoon, J. H.; Kim, S. A. Sox4 stimulates ss-catenin activity through induction of CK2 Oncol. Rep. 2011, 25, 559-565
37. Memarian, A.; Hojjat-Farsangi, M.; sgarian-Omran, H.; Younesi, V.; Jeddi-Tehrani, M.; Sharifian, R. A.; Khoshnoodi, J.; Razavi, S. M.; Rabbani, H.; Shokri, F. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia Leuk. Lymphoma 2009, 50, 2061-2070
38. Liang, Y. X.; He, H. C.; Han, Z. D.; Bi, X. C.; Dai, Q. S.; Ye, Y. K.; Qin, W. J.; Zeng, G. H.; Zhu, G.; Xu, C. L.; Zhong, W. D. CD147 and VEGF Expression in Advanced Renal Cell Carcinoma and Their Prognostic Value Cancer Invest. 2009, 27, 788-793
39. Huang, C. Y.; Beer, T. M.; Higano, C. S.; True, L. D.; Vessella, R.; Lange, P.; Garzotto, M.; Nelson, P. S. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: Identification of a cytoprotective mechanism involving growth differentiation factor 15 Clin. Cancer Res. 2007, 13, 5825-5833 (Pubitemid 47583907)
40. Tong, S.; Marjono, B.; Brown, D. A.; Mulvey, S.; Breit, S. N.; Manuelpillai, U.; Wallace, E. M. Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage Lancet 2004, 363, 129-130 (Pubitemid 38068331)
41. Johnen, H.; Lin, S.; Kuffner, T.; Brown, D. A.; Tsai, V. W. W.; Bauskin, A. R.; Wu, L.; Pankhurst, G.; Jiang, L. L.; Junankar, S.; Hunter, M.; Fairlie, W. D.; Lee, N. J.; Enriquez, R. F.; Baldock, P. A.; Corey, E.; Apple, F. S.; Murakami, M. M.; Lin, E. J.; Wang, C.; During, M. J.; Sainsbury, A.; Herzog, H.; Breit, S. N. Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1 Nat. Med. 2007, 13, 1333-1340 (Pubitemid 350073601)
42. Saeed, A. I.; Hagabati, N. K.; Braisted, J. C.; Liang, W.; Sharov, V.; Howe, E. A.; Li, J. W.; Thiagarajan, M.; White, J. A.; Quackenbush, J. TM4 microarray software suite DNA Microarrays, Part B: Databases Stat. 2006, 411, 134-193